Maier, Florian C
Wehrl, Hans F
Schmid, Andreas M
Mannheim, Julia G
Wiehr, Stefan
Lerdkrai, Chommanad
Calaminus, Carsten
Stahlschmidt, Anke
Ye, Lan
Burnet, Michael
Stiller, Detlef
Sabri, Osama
Reischl, Gerald
Staufenbiel, Mathias
Garaschuk, Olga
Jucker, Mathias
Pichler, Bernd J
Article History
Received: 20 December 2013
Accepted: 10 July 2014
First Online: 10 November 2014
Competing interests
: B.J.P. receives grant and research support from AstraZeneca, Bayer Healthcare, Boehringer-Ingelheim, Bruker, Oncodesign, Merck and Siemens; however, none of the grants is directly related to this work. D.S. is an employee of Boehringer-Ingelheim. O.S. receives grant and research support from G.E., Bayer Healthcare, Siemens, Piramal and Navidea; however, none of the grant issuers is directly related to this work. M.S. was an employee of Novartis while the studies were conducted. M.B. is the CEO of Synovo.